Unknown

Dataset Information

0

Formulation of the prefusion RSV F protein with a Th1/Th2-balanced adjuvant provides complete protection without Th2-skewed immunity in RSV-experienced young mice.


ABSTRACT: Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections among infants with most infections occurring in the first year of life. Multiple RSV exposures are required for children to mount adult-like immune responses. Although adult RSV immunity is associated with less severe disease, the protection induced through natural infection is short-lived. Therefore, vaccination of RSV-experienced young children may accelerate immunity and provide long-term protection from RSV reinfection. However, the extent to which different Th-biased vaccine regimens influence pre-existing humoral and cellular immunity in RSV-experienced young children is unknown. To address this question, infant BALB/c mice were RSV-infected and subsequently immunized with the prefusion RSV F (PreF) antigen formulated with either a Th2-skewing (Alum) or Th1/Th2-balanced (Advax-SM) adjuvant. These studies show that both adjuvants boosted neutralizing antibody and protected from RSV reinfection, but Advax-SM adjuvant prevented the Th2-skewed immunity observed in RSV-experienced young mice immunized with PreF/Alum.

SUBMITTER: Kosanovich JL 

PROVIDER: S-EPMC7540734 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7403488 | biostudies-literature
| S-EPMC9577258 | biostudies-literature
| S-EPMC7909420 | biostudies-literature
| S-EPMC3933764 | biostudies-literature
| S-EPMC7293210 | biostudies-literature
| S-EPMC8803181 | biostudies-literature
| S-EPMC4979151 | biostudies-literature
| S-EPMC4896793 | biostudies-literature
| S-EPMC6506550 | biostudies-literature
2024-07-24 | GSE241235 | GEO